CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Capsule Opacification

Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.

Organizations

Organization Involved with Phase 4 Indications (7)

  • Novartis
  • Laboratoires Thea
  • Eye Center of North Florida
  • Katholieke Universiteit Leuven
  • University of Patras
  • University of Modena and Reggio Emilia
  • Santa Maria Nuova Hospital IRCCS

Organization Involved with Phase 3 Indications (6)

  • Ocular Therapeutix, Inc.
  • Sponsor GmbH
  • Maastricht University
  • University of Toronto
  • European Society of Cataract and Refractive Surgeons
  • Zion Therapeutics, LLC

Organization Involved with Phase 2 Indications (6)

  • Allergan
  • Evolutec Group
  • Northern California Retina Vitreous Associates
  • University of British Columbia
  • Dompe Pharmaceuticals
  • Formosa Pharmaceuticals, Inc.

Organization Involved with Other Experimental Indications (4)

  • Dean Health System
  • Queen's University, Belfast
  • Yonsei University
  • Soonchunhyang University

ICD-10 crosswalk

  • H26.4 — Secondary cataract

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.